Legal Opinion
Ferring B v. v. Watson Laboratories, Inc.
Court of Appeals for the Federal Circuit
Decided August 22, 2014No. 2014-1377PublishedCited by 26 opinions
1Opinion of the Court
DYK, Circuit Judge.
Ferring Corporation (“Ferring”), the owner of U.S. Patent Nos. 7,947,739 (“the '739 patent”), 8,022,106 (“the '106 patent”), and 8,273,795 (“the '795 patent”) (collectively, the “patents-in-suit”), alleges that Apotex Corporation (“Apotex”) infringed each and every claim of the patents-in-suit by filing an Abbreviated New Drug Application (“ANDA”). The United States District Court for the District of Nevada dismissed Ferring’s claims as moot in light of Apotex’s amendment to its ANDA which rendered the ANDA non-infringing. We affirm.
BACKGROUND
Tranexamic acid, the active…
2Cases cited7 opinions
- Friends of the Earth, Inc. v. Laidlaw Environmental Services (TOC), Inc.Supreme Court of the United States · 2000
- United States v. W. T. Grant Co.Supreme Court of the United States · 1953
- County of Los Angeles v. DavisSupreme Court of the United States · 1979
- Already, LLC v. Nike, Inc.Supreme Court of the United States · 2013
- Bayer Ag and Bayer Corporation v. Elan Pharmaceutical Research Corporation and Elan Corporation, PlcCourt of Appeals for the Federal Circuit · 2000
2 more not listed; retrieve them via the Exa API.
3Cited by26 opinions
- Vanda Pharmaceuticals Inc. v. West-Ward PharmaceuticalsCourt of Appeals for the Federal Circuit · 2018
- Amgen Inc. v. Sandoz Inc.Court of Appeals for the Federal Circuit · 2019
- The Medicines Company v. Mylan, Inc.Court of Appeals for the Federal Circuit · 2017
- Cipher Pharmaceuticals Inc. v. Actavis Laboratories FL, Inc.District Court, D. New Jersey · 2015
- Salix Pharmaceuticals, Ltd. v. Norwich Pharmaceuticals Inc.Court of Appeals for the Federal Circuit · 2024
21 more not listed; retrieve them via the Exa API.